Abstract
Background
Anticoagulation of the continuous renal replacement therapy (CRRT) circuit is an important technical aspect of this medical procedure. Most studies evaluating the efficacy and safety of citrate use have been carried out in adults, and little evidence is available for the pediatric patient population. The aim of this study was to compare regional citrate anticoagulation versus systemic heparin anticoagulation in terms of the lifetime of hemofilters in a pediatric population receiving CRRT at a pediatric center in Bogota, Colombia.
Methods
This was an analytical, observational, retrospective cohort study in which we assessed the survival of 150 hemofilters (citrate group 80 hemofilters, heparin group 70 hemofilters) used in a total of 3442 hours of CCRT (citrate group 2248 h, heparin group 1194 h). Hemofilter survival was estimated beginning at placement and continuing until filter replacement due to clotting or high trans-membrane pressures.
Results
Hemofilter survival was higher in the citrate group than in the heparin group (72 vs. 18 h; p <0.0001). Bivariate analysis showed that the hemofilter coagulation risk was significantly increased when heparin was used, regardless of hemofilter size and pump flow (hazard ratio 3.70, standard error 0.82, 95% confidence interval 2.39–5.72; p <0.00001).
Conclusions
Regional citrate anticoagulation could be more effective than heparin systemic anticoagulation in terms of prolonging the hemofilter lifetime in patients with acute renal injury who require CRRT.
Similar content being viewed by others
References
Sutherland SM, Alexander SR (2012) Continuous renal replacement therapy in children. Pediatr Nephrol 27:2007–2016
Oudemans-van Straaten HM, Kellum JA, Bellomo R (2011) Clinical review: Anticoagulation for continuous renal replacement therapy-heparin or citrate? Crit Care 15:202–211
Hetzel GR, Schmitz M, Wissing H, Ries W, Schott G, Heering PJ, Isgro F, Kribben A, Himmele R, Grabensee B, Rump LC (2011) Regional citrate versus systemic heparin for anticoagulation in critically ill patients on continuous venovenous haemofiltration: a prospective randomized multicentre trial. Nephrol Dial Transplant 26:232–239
Kutsogiannis DJ, Gibney RT, Stollery T, Gao J (2005) Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients. Kidney Int 67:2361–2367
Monchi M, Berghmans D, Ledoux D, Canivet JL, Dubois D, Damas P (2004) Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study. Intensive Care Med 30:260–265
Oudemans-Van Straaten HM, Bosman RJ, Koopmans M, Van der Voot P, Wester J, Van der Spoel J, Dijksman L, Zandstra D (2009) Citrate anticoagulation for continuous venovenous hemofiltration. Crit Care Med 37:545–552
Betjes MG, van Oosterom D, van Agteren M, Van de Wetering J (2007) Regional citrate versus heparin anticoagulation during venovenous hemofiltration in patients at low risk for bleeding: similar hemofilter survival but significantly less bleeding. J Nephrol 20:602–608
Fealy N, Baldwin I, Johnstone M, Egi M, Bellomo R (2007) A pilot randomized controlled crossover study comparing regional heparinization to regional citrate anticoagulation for continuous venovenous hemofiltration. Int J Artif Organs 30:301–307
Wu MY, Hsu YH, Bai CH, Bai CH, Lin YF, Wu CH, Tam KW (2012) Regional citrate versus heparin anticoagulation for continuous renal replacement therapy: a meta-analysis of randomized controlled trials. Am J Kidney Dis 59:810–818
Zhang Z, Hongying N (2012) Efficacy and safety of regional citrate anticoagulation in critically ill patients undergoing continuous renal replacement therapy. Intensive Care Med 38:20–28
Davis TK, Neumayr T, Geile K, Doctor A, Hmeil P (2014) Citrate anticoagulation during continuous renal replacement therapy in pediatric critical care. Pediatr Crit Care Med 15:471–485
Bunchman TE, Maxvold NJ, Barnett J, Hutchings A, Benfield M (2002) Pediatric hemofiltration: Normocarb dialysate solution with citrate anticoagulation. Pediatr Nephrol 17:150–154
Bunchman TE, Maxvold NJ, Brophy PD (2003) Pediatric convective hemofiltration: Normocarb replacement fluid and citrate anticoagulation. Am J Kidney Dis 42:1248–1252
Symons JM, Brophy PD, Gregory MJ, Mcafee N, Somers MJ, Bunchman TE, Goldstein SN (2003) Continuous renal replacement therapy in children up to 10 kg. Am J Kidney Dis 41:984–989
Elhanan N, Skippen P, Nuthall G, Krahn G, Seear M (2004) Citrate anticoagulation in pediatric continuous venovenous hemofiltration. Pediatr Nephrol 19:208–212
Hothi DK, St George-Hyslop C, Geary D, Bohn D, Harvey E (2006) Continuous renal replacement therapy (CRRT) in children using the AQUARIUS. Nephrol Dial Transplant 21:2296–2300
Bunchman TE, Hackbarth RM, Maxvold NJ, Winters JW, Barletta GM (2007) Prevention of dialysis disequilibrium by use of CVVH. Int J Artif Organs 30:441–444
Rajasekaran S, Jones DP, Avent Y, Shaffer M, Elbahlawan L, Henderson N, Barfield RC, Morrison R, Tamburro RF (2010) Outcomes of hematopoietic stem cell transplant patients who received continuous renal replacement therapy in a pediatric oncology intensive care unit. Pediatr Crit Care Med 11:699–706
Symons JM, Chua AN, Somers MJ, Baum M, Bunchman T, Benfield M, Brophy P, Blowey D, Fortenberry J, Chand D, Flores F, Hackbarth R, Alexander S, Mahan J, Mcbryde K, Goldstein S (2007) Demographic characteristics of pediatric continuous renal replacement therapy: A report of the prospective pediatric continuous renal replacement therapy registry. Clin J Am Soc Nephrol 2:732–738
Brophy PD, Somers MJ, Baum MA, Symons J, Mcafee N, Fortenberry J, Rogers K, Barnett J, Blowey D, Baker C, Bunchman T, Goldstein S (2005) Multi-centre evaluation of anticoagulation in patients receiving continuous renal replacement therapy (CRRT). Nephrol Dial Transplant 20:1416–1421
Askenazi DJ, Goldstein SL, Koralkar R, Fortenberry J, Baum M, Hackbarth R, Blowey D, Bunchman TE, Brophy PD, Symons J, Chua A, Flores F, Somers MJ (2013) Continuous renal replacement therapy for children ≤10 kg: A report from the prospective pediatric continuous renal replacement therapy registry. J Pediatr 162:587.e3–592.e3
Chadha V, Garg U, Warady B, Alon U (2002) Citrate clearance in children receiving continuous venovenous renal replacement therapy. Pediatr Nephrol 17:819–824
Kreuzer M, Bonze K, Buscher R, Offner G, Ehrich J, Pape L (2010) Regional citrate anticoagulation is safe in intermittent high-flux haemodialysis treatment of children and adolescents with an increased risk of bleeding. Nephrol Dial Transplant 25:3337–3342
Smoyer WE, McAdams C, Kaplan BS, Sherbotie JR (1995) Determinants of survival in pediatric continuous hemofiltration. J Am Soc Nephrol 6:1401–1409
Fernández SN, Santiago MJ, López-Herce J, García M, Del Castillo J, Alcaraz AJ, Bellón JM (2014) Citrate anticoagulation for CRRT in children: comparison with heparin. Biomed Res Int 2014:786301
Liet JM, Allain-Launay E, Gaillard-LeRoux B, Barrière F, Chenouard A, Dejode JM, Joram N (2014) Regional citrate anticoagulation for pediatric CRRT using integrated citrate software and physiological sodium concentration solutions. Pediatr Nephrol 29:1625–1631
Soltysiak J, Warzywoda A, Kociński B, Ostalska-Nowicka D, Benedyk A, Silska-Dittmar M, Zachwieja J (2014) Citrate anticoagulation for continuous renal replacement therapy in small children. Pediatr Nephrol 29:469–475
Liao YJ, Zhang L, Zeng XX, Fu P (2013) Citrate versus unfractionated heparin for anticoagulation in continuous renal replacement therapy. Chin Med J 126:1344–1349
Basu RK, Devarajan P, Wong H, Wheeler DS (2011) An update and review of acute kidney injury in pediatrics. Pediatr Crit Care Med 12:339–347
Fortenberry J, Paden M, Goldstein (2013) Acute kidney injury in children: an update on diagnosis and treatment. Pediatr Clin N Am 60:669–688
Morgera S, Scholle C, Voss G, Haase M, Vargas-Hein O, Krausch D, Melzer C, Rosseau S, Zuckermann-Becker H, Neumayer HH (2004) Metabolic complications during regional citrate anticoagulation in continuous venovenous hemodialysis: single-center experience. Nephron 97:c131–c136
Swartz R, Pasko D, O’Toole J, Starmann B (2004) Improving the delivery of continuous renal replacement therapy using regional citrate anticoagulation. Clin Nephrol 61:134–143
Link A, Klingele M, Speer T, Rbah R, Poos J, Lemer-Graber A, Fliser D, Bohm M (2012) Total-to-ionized calcium ratio predicts mortality in continuous renal replacement therapy with citrate anticoagulation in critically ill patients. Crit Care 16:R97
Kozik-Jaromin J, Nier V, Heemann U, Kreymann B, Bohler J (2009) Citrate pharmacokinetics and calcium levels during high-flux dialysis with regional citrate anticoagulation. Nephrol Dial Transplant 24:2244–2251
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare there exists no conflict of interest.
Ethics statement
This study was approved by the institutional ethics committee.
Additional information
The original version of this article was revised to correct the rendering of the name of the author Jaime Fernández Sarmiento.
An erratum to this article is available at http://dx.doi.org/10.1007/s00467-016-3568-1.
Rights and permissions
About this article
Cite this article
Rico, M.P., Fernández Sarmiento, J., Rojas Velasquez, A.M. et al. Regional citrate anticoagulation for continuous renal replacement therapy in children. Pediatr Nephrol 32, 703–711 (2017). https://doi.org/10.1007/s00467-016-3544-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-016-3544-9